4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-049970
EVP, Research & CSO sold 3,805 shares at an average $29.99 ($114,098)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-09-08 | Option exercise | +3,805 | $1.53 | $5,822 | 23,805 | D |
| Virgin Herbert EVP, Research & CSO | 2020-09-08 | Sale | −1,465 | $30.00 | $43,950 | 22,340 | D |
| Virgin Herbert EVP, Research & CSO | 2020-09-08 | Sale | −2,340 | $29.98 | $70,148 | 20,000 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-09-08 | Option exercise · Stock Option (Right to Buy) | −3,805 | 470,890 | D | ||
| Open-market sales · 3,805 sh · avg $29.99 · $114,098 | |||||||
Loading xslF345X03/doc4.xml…